AR017052A1 - Derivados del acido carboxilico y su uso para preparar medicamentos. - Google Patents
Derivados del acido carboxilico y su uso para preparar medicamentos.Info
- Publication number
- AR017052A1 AR017052A1 ARP980104402A ARP980104402A AR017052A1 AR 017052 A1 AR017052 A1 AR 017052A1 AR P980104402 A ARP980104402 A AR P980104402A AR P980104402 A ARP980104402 A AR P980104402A AR 017052 A1 AR017052 A1 AR 017052A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- optionally substituted
- phenyl
- sulfur
- oxygen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/38—One oxygen atom attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/44—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Derivados del ácido carboxílico de formula I caracterizados porque R significa tetrazol o un grupo II en donde R1 tiene el siguiente significado: unresto OR7, en donde R7 significa: hidrogeno, el cation de un metal alcalino, el cation de un metal alcalinotérreo o un ion amonio orgánico fisiologicamentetolerable; cicloalquilo C3-8, alquilo C1-8, CH2-fenilo eventualmente sustituido, un grupo alquenilo C3-6 o alquinilo C3-6 eventualmente sustituido o feniloeventualmente sustituido. R2 significa hidrogeno, hidroxi, NH2, NH(alquilo C1-4), N(alquilo C1-4)2, halogeno, alquilo C1-4, alquenilo C2-4, alquinilo C2-4,halogenoalquilo C1-4, alcoxi C1-4, halogenoalcoxi C1-4 o alquiltio C1-4, o CR2 está unido con CR10 como se indica más abajo como un anillo de 5 o 6 miembros, Xsignifica nitrogeno o metino; Y significa nitrogeno o metino; W significa nitrogeno o CR10 en donde R10 significa H o alquilo C1-4, o CR10 junto con CR2 o CR3forma un anillo alquileno o alquenileno de 5 o 6 miembros,el cual puede estar eventualmente sustituido,y en donde en cada caso uno o más grupos metileno puedenestar reemplazados por oxígeno, azufre,-NH o -N(alquilo C1-4); R3 significa H, hidroxi, NH2, NH(alquilo C1-4), N(alquilo C1-4)2, halogeno, alquilo C1-4,alqueniloC2-4, alquinilo C2-4, halogenoalquilo C1-4, alcoxi C1-4, halogenoalcoxi C1-4, alquiltio C1-4, o CR2 está unido con CR10 como se indica más arribacomo un anillo de 5 o 6 miembros; R4 y R5 (que pueden ser iguales o diferentes) significan: fenilo o naftilo, eventualmente sustituido, o fenilo o naftilo, quepueden estar unidos entre sí en posicion orto a través de una ligadura directa, un grupo metileno, etileno o etenileno, un átomo de oxígeno o azufre o un grupoSO2, NH o N-alquilo, cicloalquilo C3-8 eventualmente sustituido; R6 significa cicloalquilo C3-8 eventualmente sustituido; fenilo o naftilo, eventualmentesustituido, un compuesto heteroaromático de 5 o 6 miembros que contienen uno a 3 átomos de nitrogeno y/o un átomo de azufre u oxígenoy el cual puede estareventualmente sustituido; Z significa azufre u oxígeno; B significa alquileno C2-4; Het significa un resto heterocíclico de la formula general Ia o Ib con T=O
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19738578A DE19738578A1 (de) | 1997-09-04 | 1997-09-04 | Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten |
| DE1998111915 DE19811915A1 (de) | 1998-03-18 | 1998-03-18 | Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR017052A1 true AR017052A1 (es) | 2001-08-22 |
Family
ID=26039663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980104402A AR017052A1 (es) | 1997-09-04 | 1998-09-03 | Derivados del acido carboxilico y su uso para preparar medicamentos. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1009741A1 (es) |
| JP (1) | JP2001514254A (es) |
| KR (1) | KR20010023615A (es) |
| CN (1) | CN1269792A (es) |
| AR (1) | AR017052A1 (es) |
| AU (1) | AU748610B2 (es) |
| BG (1) | BG104222A (es) |
| BR (1) | BR9811631A (es) |
| CA (1) | CA2302350A1 (es) |
| CO (1) | CO4970738A1 (es) |
| HR (1) | HRP980484A2 (es) |
| HU (1) | HUP0004935A3 (es) |
| ID (1) | ID25620A (es) |
| IL (1) | IL134276A0 (es) |
| NO (1) | NO20001077L (es) |
| NZ (1) | NZ502660A (es) |
| PL (1) | PL338954A1 (es) |
| SK (1) | SK1522000A3 (es) |
| TR (1) | TR200000602T2 (es) |
| TW (1) | TW546295B (es) |
| WO (1) | WO1999011629A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19924892A1 (de) * | 1999-06-01 | 2000-12-07 | Basf Ag | Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten |
| US20090263472A1 (en) * | 2006-05-29 | 2009-10-22 | Nicox S.A. | Endothelin receptor antagonist derivatives |
| PL2268644T3 (pl) | 2008-03-05 | 2012-01-31 | Boehringer Ingelheim Int | Tricykliczne pochodne piperydyny, leki zawierające te związki, ich zastosowanie i sposoby ich wytwarzania |
| JP5531097B2 (ja) * | 2009-07-10 | 2014-06-25 | カディラ・ヘルスケア・リミテッド | アンブリセンタンを調製するための改善された方法およびその新規な中間体 |
| US20120053197A1 (en) | 2010-02-19 | 2012-03-01 | Boehringer Ingelheim International Gmbh | Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| US9150583B2 (en) | 2011-08-17 | 2015-10-06 | Boehringer Ingelheim International Gmbh | Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4411225A1 (de) * | 1994-03-31 | 1995-10-05 | Basf Ag | Verwendung von Carbonsäurederivaten als Arzneimittel |
| DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| JP2000504013A (ja) * | 1996-02-01 | 2000-04-04 | スミスクライン・ビーチャム・コーポレイション | エンドセリンレセプターアンタゴニスト |
| DE19614542A1 (de) * | 1996-04-12 | 1997-10-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| DE19636046A1 (de) * | 1996-09-05 | 1998-03-12 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten |
-
1998
- 1998-08-24 HU HU0004935A patent/HUP0004935A3/hu unknown
- 1998-08-24 SK SK152-2000A patent/SK1522000A3/sk unknown
- 1998-08-24 KR KR1020007002264A patent/KR20010023615A/ko not_active Application Discontinuation
- 1998-08-24 CN CN98808862A patent/CN1269792A/zh active Pending
- 1998-08-24 CA CA002302350A patent/CA2302350A1/en not_active Abandoned
- 1998-08-24 IL IL13427698A patent/IL134276A0/xx unknown
- 1998-08-24 BR BR9811631-2A patent/BR9811631A/pt not_active IP Right Cessation
- 1998-08-24 JP JP2000508669A patent/JP2001514254A/ja active Pending
- 1998-08-24 PL PL98338954A patent/PL338954A1/xx unknown
- 1998-08-24 AU AU95333/98A patent/AU748610B2/en not_active Ceased
- 1998-08-24 NZ NZ502660A patent/NZ502660A/en unknown
- 1998-08-24 WO PCT/EP1998/005354 patent/WO1999011629A1/de not_active Application Discontinuation
- 1998-08-24 EP EP98948859A patent/EP1009741A1/de not_active Withdrawn
- 1998-08-24 TR TR2000/00602T patent/TR200000602T2/xx unknown
- 1998-08-24 ID IDW20000386D patent/ID25620A/id unknown
- 1998-09-02 HR HR19811915.1A patent/HRP980484A2/hr not_active Application Discontinuation
- 1998-09-03 AR ARP980104402A patent/AR017052A1/es not_active Application Discontinuation
- 1998-09-03 TW TW087114595A patent/TW546295B/zh active
- 1998-09-03 CO CO98050561A patent/CO4970738A1/es unknown
-
2000
- 2000-03-02 NO NO20001077A patent/NO20001077L/no not_active Application Discontinuation
- 2000-03-06 BG BG104222A patent/BG104222A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU748610B2 (en) | 2002-06-06 |
| CA2302350A1 (en) | 1999-03-11 |
| BR9811631A (pt) | 2000-09-26 |
| CN1269792A (zh) | 2000-10-11 |
| CO4970738A1 (es) | 2000-11-07 |
| PL338954A1 (en) | 2000-12-04 |
| JP2001514254A (ja) | 2001-09-11 |
| HUP0004935A3 (en) | 2001-12-28 |
| BG104222A (en) | 2001-02-28 |
| WO1999011629A1 (de) | 1999-03-11 |
| KR20010023615A (ko) | 2001-03-26 |
| NO20001077D0 (no) | 2000-03-02 |
| TW546295B (en) | 2003-08-11 |
| SK1522000A3 (en) | 2000-08-14 |
| HRP980484A2 (en) | 1999-06-30 |
| EP1009741A1 (de) | 2000-06-21 |
| IL134276A0 (en) | 2001-04-30 |
| NO20001077L (no) | 2000-03-02 |
| ID25620A (id) | 2000-10-19 |
| TR200000602T2 (tr) | 2000-12-21 |
| HUP0004935A2 (hu) | 2001-10-28 |
| AU9533398A (en) | 1999-03-22 |
| NZ502660A (en) | 2002-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5611131A2 (es) | Derivados de 5-feniltiazol y su uso como inhibidores de pi3 cinasa | |
| NO20013379L (no) | 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler | |
| CO5290250A1 (es) | 1, 2, 3, 4-tetrahidroquinolinas 2-sustituidas 4-amino sustituidas | |
| AR034985A1 (es) | Compuesto biciclico; produccion y uso del mismo | |
| AR078875A2 (es) | Compuesto uracilo composicion herbicida que lo comprende, metodo para controlar malezas con el mismo, su uso. | |
| AR054088A1 (es) | Triazoles como inhibidores de proteinquinasas. composiciones farmaceuticas | |
| AR048641A1 (es) | Compuestos de aril- o heteroarilamida ortosustituidos utiles como antago-nistas del receptor de prostaglandinas e2; composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicame | |
| AR011913A1 (es) | Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos. | |
| BR0312882A (pt) | Derivados de pleuromutilina como antimicrobianos | |
| CO5631436A2 (es) | Amidas y acidos derivados del bencimidazol para el tratamiento del dolor y la inflamacion | |
| AR052458A1 (es) | Amino-imidazolonas para la inhibicion de beta-secretasa | |
| AR077043A2 (es) | Pirimidinonas biciclicas y sus usos | |
| CO4900070A1 (es) | NUEVOS DERIVADOS DE ACIDO CARBONICO, SU PRODUCCION Y APLICA- CION COMO ANTAGONISTAS MIXTOS DE RECEPTORES ET(sub A)/ET- (sub B) | |
| AR026352A1 (es) | Derivados de imidazopiridina como inhibidores de la fosfodiesterasa vii. | |
| AR005229A1 (es) | Un derivado de 2,3-dioxo-1,2,3,4-tetrahidro-quinoxaliil y una composicion farmaceutica que lo comprende. | |
| DK0790987T3 (da) | Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer | |
| CO5631434A2 (es) | Derivados de piridina-carboxamida y su uso como plaguicidas | |
| AR024918A1 (es) | Derivados de ciclobuteno, su preparacion y sus usos terapeuticos. | |
| AR017052A1 (es) | Derivados del acido carboxilico y su uso para preparar medicamentos. | |
| CO5060426A1 (es) | 1-aril-3-imidiopirazoles plaguicidas | |
| CO5261622A1 (es) | Inhibidores de la proteinasa c del procolageno | |
| CO5180631A1 (es) | Derivados de bencimidazol sustituidos con aminocarbonilo, procedimientos para su preparacion y su utilizacion como medicamentos | |
| CO4900038A1 (es) | Nuevos derivados de acidos carboxilicos, su obtencion y aplicacion | |
| ES2055115T3 (es) | Derivados de fenil-amidina y fenil-guanidina sustituidos en posicion orto y agentes antidiabeticos y hipoglicemicos que los contienen. | |
| CO4950605A1 (es) | Nuevos derivados b-amino y b-azido de acido carbonico, su produccion y aplicacion como antagonistas de receptores de endotelina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |